Skip to main content
Tiziana Life Sciences Ltd logo

Tiziana Life Sciences Ltd — Investor Relations & Filings

Ticker · TLSA ISIN · BMG889121031 LEI · 984500769407C5E46F42 US Professional, scientific and technical activities
Open in API
Filings indexed 460 across all filing types
Latest filing 2020-06-02 Regulatory Filings
Country BM Bermuda
Listing US TLSA

About Tiziana Life Sciences Ltd

https://www.tizianalifesciences.com/

Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company focused on developing innovative immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's core strategy involves utilizing alternative drug delivery routes, such as intranasal administration, to modulate the immune system. Its lead clinical candidate, foralumab (TZLS-401), is the only fully human anti-CD3 monoclonal antibody being investigated for neurological conditions. Foralumab is in clinical development for the treatment of Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS), Alzheimer's disease, Amyotrophic Lateral Sclerosis (ALS), and Multiple System Atrophy (MSA). The company's pipeline also includes an anti-IL-6 receptor monoclonal antibody (TZLS-501) for potential application in lung diseases.

Recent filings

Filing Released Lang Actions
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Tiziana Life Sciences plc, with the SEC. It references a Regulatory News Service (RNS) announcement about a correction related to exercise of warrants, issue of equity, and total voting rights. The document itself is short (2777 characters) and primarily serves to furnish the RNS announcement as an exhibit. It explicitly states that the information is being furnished and not filed, and it does not contain substantive financial data or detailed report content. Therefore, this document is an announcement of a regulatory filing rather than a full financial or operational report. According to the rules, such documents should be classified as Regulatory Filings (RNS) since they do not fit other specific categories and are not the report itself but an announcement or furnishing of information.
2020-06-02 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 100% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references an attached Regulatory News Service (RNS) announcement about the exercise of warrants, issue of equity, and total voting rights. The document itself is short (2931 characters) and primarily serves to furnish the RNS announcement rather than containing substantive financial data or detailed report content. According to the rules, such documents that provide regulatory announcements or compliance information without detailed financial statements or analysis should be classified as Regulatory Filings (RNS).
2020-06-02 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references an attached Regulatory News Service (RNS) announcement about the appointment of a broker. The document is short (2891 characters) and primarily serves to furnish this announcement rather than provide detailed financial data or a full report. According to the MENU VS MEAL RULE, this is an announcement of a report rather than the report itself. Therefore, it should be classified as a Regulatory Filings (RNS) filing type, which is the fallback category for miscellaneous filings that do not fit other specific categories.
2020-06-01 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It contains a regulatory news service announcement about the company's intention to demerge a business unit. The document is short (2975 characters) and primarily serves to furnish an announcement rather than provide detailed financial data or a full report. It explicitly states that the attached announcement is furnished and not filed for certain regulatory purposes. There is no substantive financial data or detailed report content. Therefore, this document is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2020-05-22 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Tiziana Life Sciences plc, pursuant to the SEC rules. It primarily furnishes a Regulatory News Service (RNS) announcement from the UK about abstracts published at a clinical oncology conference. The document explicitly states that the attached RNS announcement is being furnished and is not "filed" for purposes of Section 18 of the Securities Exchange Act. The document length is short (3086 characters), and it mainly serves to provide regulatory news rather than detailed financial data or management discussion. There is no substantive financial report or detailed analysis present. Therefore, this filing is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements and filings that do not fit other specific categories.
2020-05-14 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It contains a Regulatory News Service (RNS) announcement about data demonstrating StemPrintER's superiority in breast cancer prognostics. The document explicitly states that the RNS announcement is furnished as Exhibit 99.1 and is not "filed" for purposes of Section 18, indicating it is an announcement rather than a full report. The document length is 3093 characters, which is relatively short and consistent with an announcement rather than a full report. There is no substantive financial data or detailed report content, only a reference to the RNS announcement. Therefore, this document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings and announcements that do not fit other specific categories.
2020-05-14 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.